Analysis of factor VIII inhibitors in a haemophilia A patient with an Arg593→Cys mutation using phage display

被引:8
作者
Bril, WS
Turenhout, EAM
Kaijen, PHP
van den Brink, EN
Koopman, MMW
Peters, M
Voorberg, J
机构
[1] CLB, Sanquin Res, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat, NL-1105 AZ Amsterdam, Netherlands
关键词
factor VIII inhibitors; haemophilia A; phage display; B lymphocyte; immunoglobulin repertoire;
D O I
10.1046/j.1365-2141.2002.03856.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We characterized anti-factor VIII antibodies in a mild haemophilia A patient with an Arg(593)-->Cys mutation in the A2 domain, using V gene phage-display technology. All isolated single-chain variable-domain antibody fragments were directed against residues Arg(484)-Ile(508), a binding site for factor VIII inhibitors in the A2 domain. After a further period of replacement therapy, a transient rise in inhibitor titre was observed. These antibodies were directed against the A2 domain. Activation of a pre-existing pool of B cells, which express antibodies against residues Arg(484)-Ile(508), could explain the rapid anamnestic response.
引用
收藏
页码:393 / 396
页数:4
相关论文
共 12 条
[1]   The missense mutation Arg(593)->Cys is related to antibody formation in a patient with mild hemophilia A [J].
Fijnvandraat, K ;
Turenhout, EAM ;
vandenBrink, EN ;
tenCate, JW ;
vanMourik, JA ;
Peters, M ;
Voorberg, J .
BLOOD, 1997, 89 (12) :4371-4377
[2]   Balancing immunity and tolerance: Deleting and tuning lymphocyte repertoires [J].
Goodnow, CC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) :2264-2271
[3]  
Hay CRM, 1998, THROMB HAEMOSTASIS, V79, P762
[4]   Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes:: CD27 as a general marker for somatically mutated (memory) B cells [J].
Klein, U ;
Rajewsky, K ;
Küppers, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) :1679-1689
[5]  
MacLennan I C, 1997, Semin Immunol, V9, P229, DOI 10.1006/smim.1997.0078
[6]   Medical progress - The hemophilias - From royal genes to gene therapy [J].
Mannucci, PM ;
Tuddenham, EGD .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (23) :1773-1779
[7]   Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs [J].
Ochsenbein, AF ;
Pinschewer, DD ;
Sierro, S ;
Horvath, E ;
Hengartner, H ;
Zinkernagel, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (24) :13263-13268
[8]  
SULTAN Y, 1992, THROMB HAEMOSTASIS, V67, P600
[9]   Loss of tolerance to exogenous and endogenous factor VIII in a mild hemophilia a patient with an Arg(593) to Cys mutation [J].
Thompson, AR ;
Murphy, MEP ;
Liu, ML ;
Saenko, EL ;
Healey, JF ;
Lollar, P ;
Scandella, D .
BLOOD, 1997, 90 (05) :1902-1910
[10]  
TOMLINSON IM, 1999, V BASE SEQUENCE DIRE